1 Study Coverage 1.1 Crude Unfractionated Heparin (UFH) Product Introduction 1.2 Market by Type 1.2.1 Global Crude Unfractionated Heparin (UFH) Market Size Growth Rate by Type 1.2.2 Pig Intestine Mucosa Heparin 1.2.3 Bovine Heparin and Others 1.3 Market by Application 1.3.1 Global Crude Unfractionated Heparin (UFH) Market Size Growth Rate by Application 1.3.2 Unfractionated Heparin (UFH) 1.3.3 Low-Molecular-Weight Heparin (LMWH) 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Crude Unfractionated Heparin (UFH) Market Size, Estimates and Forecasts 2.1.1 Global Crude Unfractionated Heparin (UFH) Revenue 2016-2027 2.1.2 Global Crude Unfractionated Heparin (UFH) Sales 2016-2027 2.2 Global Crude Unfractionated Heparin (UFH), Market Size by Region: 2016 VS 2021 VS 2027 2.3 Crude Unfractionated Heparin (UFH) Historical Market Size by Region (2016-2021) 2.3.1 Global Crude Unfractionated Heparin (UFH) Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Crude Unfractionated Heparin (UFH) Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Crude Unfractionated Heparin (UFH) Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Crude Unfractionated Heparin (UFH) Sales Forecast by Region (2022-2027) 2.4.2 Global Crude Unfractionated Heparin (UFH) Revenue Forecast by Region (2022-2027) 3 Global Crude Unfractionated Heparin (UFH) Competitor Landscape by Players 3.1 Global Top Crude Unfractionated Heparin (UFH) Manufacturers by Sales 3.1.1 Global Crude Unfractionated Heparin (UFH) Sales by Manufacturer (2016-2021) 3.1.2 Global Crude Unfractionated Heparin (UFH) Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Crude Unfractionated Heparin (UFH) Manufacturers by Revenue 3.2.1 Key Crude Unfractionated Heparin (UFH) Manufacturers Covered: Ranking by Revenue 3.2.2 Global Crude Unfractionated Heparin (UFH) Revenue by Manufacturers (2016-2021) 3.2.3 Global Crude Unfractionated Heparin (UFH) Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Crude Unfractionated Heparin (UFH) Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Crude Unfractionated Heparin (UFH) Revenue in 2020 3.2.6 Global Crude Unfractionated Heparin (UFH) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Crude Unfractionated Heparin (UFH) Price by Manufacturers 3.4 Global Crude Unfractionated Heparin (UFH) Manufacturing Base Distribution, Product Types 3.4.1 Crude Unfractionated Heparin (UFH) Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Crude Unfractionated Heparin (UFH) Product Type 3.4.3 Date of International Manufacturers Enter into Crude Unfractionated Heparin (UFH) Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Crude Unfractionated Heparin (UFH) Market Size by Type (2016-2021) 4.1.1 Global Crude Unfractionated Heparin (UFH) Sales by Type (2016-2021) 4.1.2 Global Crude Unfractionated Heparin (UFH) Revenue by Type (2016-2021) 4.1.3 Crude Unfractionated Heparin (UFH) Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Crude Unfractionated Heparin (UFH) Market Size Forecast by Type (2022-2027) 4.2.1 Global Crude Unfractionated Heparin (UFH) Sales Forecast by Type (2022-2027) 4.2.2 Global Crude Unfractionated Heparin (UFH) Revenue Forecast by Type (2022-2027) 4.2.3 Crude Unfractionated Heparin (UFH) Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Crude Unfractionated Heparin (UFH) Market Size by Application (2016-2021) 5.1.1 Global Crude Unfractionated Heparin (UFH) Sales by Application (2016-2021) 5.1.2 Global Crude Unfractionated Heparin (UFH) Revenue by Application (2016-2021) 5.1.3 Crude Unfractionated Heparin (UFH) Price by Application (2016-2021) 5.2 Crude Unfractionated Heparin (UFH) Market Size Forecast by Application (2022-2027) 5.2.1 Global Crude Unfractionated Heparin (UFH) Sales Forecast by Application (2022-2027) 5.2.2 Global Crude Unfractionated Heparin (UFH) Revenue Forecast by Application (2022-2027) 5.2.3 Global Crude Unfractionated Heparin (UFH) Price Forecast by Application (2022-2027) 6 Japan by Players, Type and Application 6.1 Japan Crude Unfractionated Heparin (UFH) Market Size YoY Growth 2016-2027 6.1.1 Japan Crude Unfractionated Heparin (UFH) Sales YoY Growth 2016-2027 6.1.2 Japan Crude Unfractionated Heparin (UFH) Revenue YoY Growth 2016-2027 6.1.3 Japan Crude Unfractionated Heparin (UFH) Market Share in Global Market 2016-2027 6.2 Japan Crude Unfractionated Heparin (UFH) Market Size by Players (International and Local Players) 6.2.1 Japan Top Crude Unfractionated Heparin (UFH) Players by Sales (2016-2021) 6.2.2 Japan Top Crude Unfractionated Heparin (UFH) Players by Revenue (2016-2021) 6.3 Japan Crude Unfractionated Heparin (UFH) Historic Market Review by Type (2016-2021) 6.3.1 Japan Crude Unfractionated Heparin (UFH) Sales Market Share by Type (2016-2021) 6.3.2 Japan Crude Unfractionated Heparin (UFH) Revenue Market Share by Type (2016-2021) 6.3.3 Japan Crude Unfractionated Heparin (UFH) Price by Type (2016-2021) 6.4 Japan Crude Unfractionated Heparin (UFH) Market Estimates and Forecasts by Type (2022-2027) 6.4.1 Japan Crude Unfractionated Heparin (UFH) Sales Forecast by Type (2022-2027) 6.4.2 Japan Crude Unfractionated Heparin (UFH) Revenue Forecast by Type (2022-2027) 6.4.3 Japan Crude Unfractionated Heparin (UFH) Price Forecast by Type (2022-2027) 6.5 Japan Crude Unfractionated Heparin (UFH) Historic Market Review by Application (2016-2021) 6.5.1 Japan Crude Unfractionated Heparin (UFH) Sales Market Share by Application (2016-2021) 6.5.2 Japan Crude Unfractionated Heparin (UFH) Revenue Market Share by Application (2016-2021) 6.5.3 Japan Crude Unfractionated Heparin (UFH) Price by Application (2016-2021) 6.6 Japan Crude Unfractionated Heparin (UFH) Market Estimates and Forecasts by Application (2022-2027) 6.6.1 Japan Crude Unfractionated Heparin (UFH) Sales Forecast by Application (2022-2027) 6.6.2 Japan Crude Unfractionated Heparin (UFH) Revenue Forecast by Application (2022-2027) 6.6.3 Japan Crude Unfractionated Heparin (UFH) Price Forecast by Application (2022-2027) 7 North America 7.1 North America Crude Unfractionated Heparin (UFH) Market Size YoY Growth 2016-2027 7.2 North America Crude Unfractionated Heparin (UFH) Market Facts & Figures by Country 7.2.1 North America Crude Unfractionated Heparin (UFH) Sales by Country (2016-2021) 7.2.2 North America Crude Unfractionated Heparin (UFH) Revenue by Country (2016-2021) 7.2.3 United States 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Crude Unfractionated Heparin (UFH) Market Size YoY Growth 2016-2027 8.2 Asia Pacific Crude Unfractionated Heparin (UFH) Market Facts & Figures by Region 8.2.1 Asia Pacific Crude Unfractionated Heparin (UFH) Sales by Region (2016-2021) 8.2.2 Asia Pacific Crude Unfractionated Heparin (UFH) Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 9 Europe 9.1 Europe Crude Unfractionated Heparin (UFH) Market Size YoY Growth 2016-2027 9.2 Europe Crude Unfractionated Heparin (UFH) Market Facts & Figures by Country 9.2.1 Europe Crude Unfractionated Heparin (UFH) Sales by Country (2016-2021) 9.2.2 Europe Crude Unfractionated Heparin (UFH) Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Crude Unfractionated Heparin (UFH) Market Size YoY Growth 2016-2027 10.2 Latin America Crude Unfractionated Heparin (UFH) Market Facts & Figures by Country 10.2.1 Latin America Crude Unfractionated Heparin (UFH) Sales by Country (2016-2021) 10.2.2 Latin America Crude Unfractionated Heparin (UFH) Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Crude Unfractionated Heparin (UFH) Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Crude Unfractionated Heparin (UFH) Market Facts & Figures by Country 11.2.1 Middle East and Africa Crude Unfractionated Heparin (UFH) Sales by Country (2016-2021) 11.2.2 Middle East and Africa Crude Unfractionated Heparin (UFH) Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Bioiberica 12.1.1 Bioiberica Corporation Information 12.1.2 Bioiberica Description and Business Overview 12.1.3 Bioiberica Crude Unfractionated Heparin (UFH) Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Bioiberica Crude Unfractionated Heparin (UFH) Products Offered 12.1.5 Bioiberica Recent Development 12.2 Shenzhen Hepalink 12.2.1 Shenzhen Hepalink Corporation Information 12.2.2 Shenzhen Hepalink Description and Business Overview 12.2.3 Shenzhen Hepalink Crude Unfractionated Heparin (UFH) Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Shenzhen Hepalink Crude Unfractionated Heparin (UFH) Products Offered 12.2.5 Shenzhen Hepalink Recent Development 12.3 Sanofi 12.3.1 Sanofi Corporation Information 12.3.2 Sanofi Description and Business Overview 12.3.3 Sanofi Crude Unfractionated Heparin (UFH) Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Sanofi Crude Unfractionated Heparin (UFH) Products Offered 12.3.5 Sanofi Recent Development 12.4 Nanjing King-friend 12.4.1 Nanjing King-friend Corporation Information 12.4.2 Nanjing King-friend Description and Business Overview 12.4.3 Nanjing King-friend Crude Unfractionated Heparin (UFH) Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Nanjing King-friend Crude Unfractionated Heparin (UFH) Products Offered 12.4.5 Nanjing King-friend Recent Development 12.5 Fengrun Biological Technology 12.5.1 Fengrun Biological Technology Corporation Information 12.5.2 Fengrun Biological Technology Description and Business Overview 12.5.3 Fengrun Biological Technology Crude Unfractionated Heparin (UFH) Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Fengrun Biological Technology Crude Unfractionated Heparin (UFH) Products Offered 12.5.5 Fengrun Biological Technology Recent Development 12.6 Aspen Oss 12.6.1 Aspen Oss Corporation Information 12.6.2 Aspen Oss Description and Business Overview 12.6.3 Aspen Oss Crude Unfractionated Heparin (UFH) Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Aspen Oss Crude Unfractionated Heparin (UFH) Products Offered 12.6.5 Aspen Oss Recent Development 12.7 Hebei Changshan Biochemical 12.7.1 Hebei Changshan Biochemical Corporation Information 12.7.2 Hebei Changshan Biochemical Description and Business Overview 12.7.3 Hebei Changshan Biochemical Crude Unfractionated Heparin (UFH) Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Hebei Changshan Biochemical Crude Unfractionated Heparin (UFH) Products Offered 12.7.5 Hebei Changshan Biochemical Recent Development 12.8 Changzhou Qianhong 12.8.1 Changzhou Qianhong Corporation Information 12.8.2 Changzhou Qianhong Description and Business Overview 12.8.3 Changzhou Qianhong Crude Unfractionated Heparin (UFH) Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Changzhou Qianhong Crude Unfractionated Heparin (UFH) Products Offered 12.8.5 Changzhou Qianhong Recent Development 12.9 Hepac (Darling Ingredients) 12.9.1 Hepac (Darling Ingredients) Corporation Information 12.9.2 Hepac (Darling Ingredients) Description and Business Overview 12.9.3 Hepac (Darling Ingredients) Crude Unfractionated Heparin (UFH) Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Hepac (Darling Ingredients) Crude Unfractionated Heparin (UFH) Products Offered 12.9.5 Hepac (Darling Ingredients) Recent Development 12.10 Huaian MDC Pharmaceutical 12.10.1 Huaian MDC Pharmaceutical Corporation Information 12.10.2 Huaian MDC Pharmaceutical Description and Business Overview 12.10.3 Huaian MDC Pharmaceutical Crude Unfractionated Heparin (UFH) Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Huaian MDC Pharmaceutical Crude Unfractionated Heparin (UFH) Products Offered 12.10.5 Huaian MDC Pharmaceutical Recent Development 12.11 Bioiberica 12.11.1 Bioiberica Corporation Information 12.11.2 Bioiberica Description and Business Overview 12.11.3 Bioiberica Crude Unfractionated Heparin (UFH) Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Bioiberica Crude Unfractionated Heparin (UFH) Products Offered 12.11.5 Bioiberica Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Crude Unfractionated Heparin (UFH) Industry Trends 13.2 Crude Unfractionated Heparin (UFH) Market Drivers 13.3 Crude Unfractionated Heparin (UFH) Market Challenges 13.4 Crude Unfractionated Heparin (UFH) Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Crude Unfractionated Heparin (UFH) Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Crude Unfractionated Heparin (UFH) Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Pig Intestine Mucosa Heparin Table 3. Major Manufacturers of Bovine Heparin and Others Table 4. Global Crude Unfractionated Heparin (UFH) Market Size Growth Rate by Application (2021-2027) & (Kiloton) Table 5. Global Crude Unfractionated Heparin (UFH) Market Size by Region (Kiloton) & (US$ Million), 2016 VS 2021 VS 2027 Table 6. Global Crude Unfractionated Heparin (UFH) Sales by Regions (2016-2021) & (Kiloton) Table 7. Global Crude Unfractionated Heparin (UFH) Sales Market Share by Regions (2016-2021) Table 8. Global Crude Unfractionated Heparin (UFH) Revenue by Regions (2016-2021) & (US$ Million) Table 9. Global Crude Unfractionated Heparin (UFH) Sales Forecast by Region (2022-2027) & (Kiloton) Table 10. Global Crude Unfractionated Heparin (UFH) Sales Market Share Forecast by Region (2022-2027) Table 11. Global Crude Unfractionated Heparin (UFH) Revenue Forecast by Region (2022-2027) & (US$ Million) Table 12. Global Crude Unfractionated Heparin (UFH) Revenue Market Share Forecast by Region (2022-2027) Table 13. Global Crude Unfractionated Heparin (UFH) Sales by Manufacturers (2016-2021) (Kiloton) Table 14. Global Crude Unfractionated Heparin (UFH) Sales Share by Manufacturers (2016-2021) Table 15. Ranking of Global Top Crude Unfractionated Heparin (UFH) Manufacturers by Revenue (US$ Million) in 2020 Table 16. Crude Unfractionated Heparin (UFH) Revenue by Manufacturers (2016-2021) (US$ Million) Table 17. Crude Unfractionated Heparin (UFH) Revenue Share by Manufacturers (2016-2021) Table 18. Global Crude Unfractionated Heparin (UFH) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 19. Global Crude Unfractionated Heparin (UFH) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Crude Unfractionated Heparin (UFH) as of 2020) Table 20. Key Manufacturers Crude Unfractionated Heparin (UFH) Price (2016-2021) (US$/Ton) Table 21. Crude Unfractionated Heparin (UFH) Manufacturers Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Crude Unfractionated Heparin (UFH) Product Type Table 23. Date of International Manufacturers Enter into Crude Unfractionated Heparin (UFH) Market Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans Table 25. Global Crude Unfractionated Heparin (UFH) Sales by Type (2016-2021) (Kiloton) Table 26. Global Crude Unfractionated Heparin (UFH) Sales Share by Type (2016-2021) Table 27. Global Crude Unfractionated Heparin (UFH) Revenue by Type (2016-2021) (US$ Million) Table 28. Global Crude Unfractionated Heparin (UFH) Revenue Share by Type (2016-2021) Table 29. Crude Unfractionated Heparin (UFH) Average Selling Price (ASP) by Type (2016-2021) & (US$/Ton) Table 30. Global Crude Unfractionated Heparin (UFH) Sales Forecast by Type (2022-2027) & (Kiloton) Table 31. Global Crude Unfractionated Heparin (UFH) Sales Market Share Forecast by Type (2022-2027) Table 32. Global Crude Unfractionated Heparin (UFH) Revenue Forecast V (2022-2027) & (US$ Million) Table 33. Global Crude Unfractionated Heparin (UFH) Revenue Market Share Forecast by Type (2022-2027) Table 34. Global Crude Unfractionated Heparin (UFH) Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Ton) Table 35. Global Crude Unfractionated Heparin (UFH) Sales by Application (2016-2021) (Kiloton) Table 36. Global Crude Unfractionated Heparin (UFH) Sales Share by Application (2016-2021) Table 37. Global Crude Unfractionated Heparin (UFH) Revenue by Application (2016-2021) (US$ Million) Table 38. Global Crude Unfractionated Heparin (UFH) Revenue Share by Application (2016-2021) Table 39. Crude Unfractionated Heparin (UFH) Average Selling Price (ASP) by Application (2016-2021) & (US$/Ton) Table 40. Global Crude Unfractionated Heparin (UFH) Sales Forecast by Application (2022-2027) & (Kiloton) Table 41. Global Crude Unfractionated Heparin (UFH) Sales Market Share Forecast by Application (2022-2027) Table 42. Global Crude Unfractionated Heparin (UFH) Revenue Forecast by Application (2022-2027) & (US$ Million) Table 43. Global Crude Unfractionated Heparin (UFH) Revenue Market Share Forecast by Application (2022-2027) Table 44. Global Crude Unfractionated Heparin (UFH) Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Ton) Table 45. Japan Crude Unfractionated Heparin (UFH) Sales (Kiloton) of Key Companies (2016-2021) Table 46. Japan Crude Unfractionated Heparin (UFH) Sales Share by Company (2016-2021) Table 47. Japan Crude Unfractionated Heparin (UFH) Revenue (US$ Million) by Company (2016-2021) Table 48. Japan Crude Unfractionated Heparin (UFH) Revenue Share by Company (2016-2021) Table 49. Japan Crude Unfractionated Heparin (UFH) Sales (Kiloton) by Type (2016-2021) Table 50. Japan Crude Unfractionated Heparin (UFH) Sales Share by Type (2016-2021) Table 51. Japan Crude Unfractionated Heparin (UFH) Revenue (US$ Million) Market Share by Type (2016-2021) Table 52. Japan Crude Unfractionated Heparin (UFH) Price (US$/Ton) by Type (2016-2021) Table 53. Japan Crude Unfractionated Heparin (UFH) Sales (Kiloton) by Type (2022-2027) Table 54. Japan Crude Unfractionated Heparin (UFH) Sales Share by Type (2022-2027) Table 55. Japan Crude Unfractionated Heparin (UFH) Revenue (US$ Million) Market Share by Type (2022-2027) Table 56. Japan Crude Unfractionated Heparin (UFH) Revenue Share by Type (2022-2027) Table 57. Japan Crude Unfractionated Heparin (UFH) Price (US$/Ton) by Type (2022-2027) Table 58. Japan Crude Unfractionated Heparin (UFH) Sales (Kiloton) by Application (2016-2021) Table 59. Japan Crude Unfractionated Heparin (UFH) Sales Share by Application (2016-2021) Table 60. Japan Crude Unfractionated Heparin (UFH) Revenue (US$ Million) Market Share by Application (2016-2021) Table 61. Japan Crude Unfractionated Heparin (UFH) Price (US$/Ton) by Application (2016-2021) Table 62. Japan Crude Unfractionated Heparin (UFH) Sales (Kiloton) by Application (2022-2027) Table 63. Japan Crude Unfractionated Heparin (UFH) Sales Share by Application (2022-2027) Table 64. Japan Crude Unfractionated Heparin (UFH) Revenue (US$ Million) Market Share by Application (2022-2027) Table 65. Japan Crude Unfractionated Heparin (UFH) Revenue Share by Application (2022-2027) Table 66. Japan Crude Unfractionated Heparin (UFH) Price (US$/Ton) by Application (2022-2027) Table 67. North America Crude Unfractionated Heparin (UFH) Sales by Country (2016-2021) & (Kiloton) Table 68. North America Crude Unfractionated Heparin (UFH) Sales Market Share by Country (2016-2021) Table 69. North America Crude Unfractionated Heparin (UFH) Revenue by Country (2016-2021) & (US$ Million) Table 70. North America Crude Unfractionated Heparin (UFH) Revenue Market Share by Country (2016-2021) Table 71. Asia Pacific Crude Unfractionated Heparin (UFH) Sales by Region (2016-2021) & (Kiloton) Table 72. Asia Pacific Crude Unfractionated Heparin (UFH) Sales Market Share by Region (2016-2021) Table 73. Asia Pacific Crude Unfractionated Heparin (UFH) Revenue by Region (2016-2021) & (US$ Million) Table 74. Asia Pacific Crude Unfractionated Heparin (UFH) Revenue Market Share by Region (2016-2021) Table 75. Europe Crude Unfractionated Heparin (UFH) Sales by Country (2016-2021) & (Kiloton) Table 76. Europe Crude Unfractionated Heparin (UFH) Sales Market Share by Country (2016-2021) Table 77. Europe Crude Unfractionated Heparin (UFH) Revenue by Country (2016-2021) & (US$ Million) Table 78. Europe Crude Unfractionated Heparin (UFH) Revenue Market Share by Country (2016-2021) Table 79. Latin America Crude Unfractionated Heparin (UFH) Sales by Country (2016-2021) & (Kiloton) Table 80. Latin America Crude Unfractionated Heparin (UFH) Sales Market Share by Country (2016-2021) Table 81. Latin Americaa Crude Unfractionated Heparin (UFH) Revenue by Country (2016-2021) & (US$ Million) Table 82. Latin America Crude Unfractionated Heparin (UFH) Revenue Market Share by Country (2016-2021) Table 83. Middle East and Africa Crude Unfractionated Heparin (UFH) Sales by Country (2016-2021) & (Kiloton) Table 84. Middle East and Africa Crude Unfractionated Heparin (UFH) Sales Market Share by Country (2016-2021) Table 85. Middle East and Africa Crude Unfractionated Heparin (UFH) Revenue by Country (2016-2021) & (US$ Million) Table 86. Middle East and Africa Crude Unfractionated Heparin (UFH) Revenue Market Share by Country (2016-2021) Table 87. Bioiberica Corporation Information Table 88. Bioiberica Description and Business Overview Table 89. Bioiberica Crude Unfractionated Heparin (UFH) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 90. Bioiberica Crude Unfractionated Heparin (UFH) Product Table 91. Bioiberica Recent Development Table 92. Shenzhen Hepalink Corporation Information Table 93. Shenzhen Hepalink Description and Business Overview Table 94. Shenzhen Hepalink Crude Unfractionated Heparin (UFH) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 95. Shenzhen Hepalink Product Table 96. Shenzhen Hepalink Recent Development Table 97. Sanofi Corporation Information Table 98. Sanofi Description and Business Overview Table 99. Sanofi Crude Unfractionated Heparin (UFH) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 100. Sanofi Product Table 101. Sanofi Recent Development Table 102. Nanjing King-friend Corporation Information Table 103. Nanjing King-friend Description and Business Overview Table 104. Nanjing King-friend Crude Unfractionated Heparin (UFH) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 105. Nanjing King-friend Product Table 106. Nanjing King-friend Recent Development Table 107. Fengrun Biological Technology Corporation Information Table 108. Fengrun Biological Technology Description and Business Overview Table 109. Fengrun Biological Technology Crude Unfractionated Heparin (UFH) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 110. Fengrun Biological Technology Product Table 111. Fengrun Biological Technology Recent Development Table 112. Aspen Oss Corporation Information Table 113. Aspen Oss Description and Business Overview Table 114. Aspen Oss Crude Unfractionated Heparin (UFH) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 115. Aspen Oss Product Table 116. Aspen Oss Recent Development Table 117. Hebei Changshan Biochemical Corporation Information Table 118. Hebei Changshan Biochemical Description and Business Overview Table 119. Hebei Changshan Biochemical Crude Unfractionated Heparin (UFH) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 120. Hebei Changshan Biochemical Product Table 121. Hebei Changshan Biochemical Recent Development Table 122. Changzhou Qianhong Corporation Information Table 123. Changzhou Qianhong Description and Business Overview Table 124. Changzhou Qianhong Crude Unfractionated Heparin (UFH) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 125. Changzhou Qianhong Product Table 126. Changzhou Qianhong Recent Development Table 127. Hepac (Darling Ingredients) Corporation Information Table 128. Hepac (Darling Ingredients) Description and Business Overview Table 129. Hepac (Darling Ingredients) Crude Unfractionated Heparin (UFH) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 130. Hepac (Darling Ingredients) Product Table 131. Hepac (Darling Ingredients) Recent Development Table 132. Huaian MDC Pharmaceutical Corporation Information Table 133. Huaian MDC Pharmaceutical Description and Business Overview Table 134. Huaian MDC Pharmaceutical Crude Unfractionated Heparin (UFH) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 135. Huaian MDC Pharmaceutical Product Table 136. Huaian MDC Pharmaceutical Recent Development Table 137. Yantai Dongcheng Biochemicals Corporation Information Table 138. Yantai Dongcheng Biochemicals Description and Business Overview Table 139. Yantai Dongcheng Biochemicals Crude Unfractionated Heparin (UFH) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 140. Yantai Dongcheng Biochemicals Product Table 141. Yantai Dongcheng Biochemicals Recent Development Table 142. Crude Unfractionated Heparin (UFH) Market Trends Table 143. Crude Unfractionated Heparin (UFH) Market Drivers Table 144. Crude Unfractionated Heparin (UFH) Market Challenges Table 145. Crude Unfractionated Heparin (UFH) Market Restraints Table 146. Crude Unfractionated Heparin (UFH) Customers List Table 147. Crude Unfractionated Heparin (UFH) Distributors List Table 148. Research Programs/Design for This Report Table 149. Key Data Information from Secondary Sources Table 150. Key Data Information from Primary Sources List of Figures Figure 1. Crude Unfractionated Heparin (UFH) Product Picture Figure 2. Global Crude Unfractionated Heparin (UFH) Sales Market Share by Type in 2020 & 2027 Figure 3. Pig Intestine Mucosa Heparin Product Picture Figure 4. Bovine Heparin and Others Product Picture Figure 5. Global Crude Unfractionated Heparin (UFH) Sales Market Share by Application in 2020 & 2027 Figure 6. Unfractionated Heparin (UFH) Figure 7. Low-Molecular-Weight Heparin (LMWH) Figure 8. Crude Unfractionated Heparin (UFH) Report Years Considered Figure 9. Global Crude Unfractionated Heparin (UFH) Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Crude Unfractionated Heparin (UFH) Market Size 2016-2027 (US$ Million) Figure 11. Global Crude Unfractionated Heparin (UFH) Sales 2016-2027 (Kiloton) Figure 12. Global Crude Unfractionated Heparin (UFH) Market Size Market Share by Region: 2021 Versus 2027 Figure 13. Global Crude Unfractionated Heparin (UFH) Sales Market Share by Region (2016-2021) Figure 14. Global Crude Unfractionated Heparin (UFH) Sales Market Share by Region in 2020 Figure 15. Global Crude Unfractionated Heparin (UFH) Revenue Market Share by Region (2016-2021) Figure 16. Global Crude Unfractionated Heparin (UFH) Revenue Market Share by Region in 2020 Figure 17. Global Crude Unfractionated Heparin (UFH) Sales Share by Manufacturer in 2020 Figure 18. The Top 10 and 5 Players Market Share by Crude Unfractionated Heparin (UFH) Revenue in 2020 Figure 19. Crude Unfractionated Heparin (UFH) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 20. Global Crude Unfractionated Heparin (UFH) Sales Market Share by Type (2016-2021) Figure 21. Global Crude Unfractionated Heparin (UFH) Sales Market Share by Type in 2020 Figure 22. Global Crude Unfractionated Heparin (UFH) Revenue Market Share by Type (2016-2021) Figure 23. Global Crude Unfractionated Heparin (UFH) Revenue Market Share by Type in 2020 Figure 24. Global Crude Unfractionated Heparin (UFH) Sales Market Share by Application (2016-2021) Figure 25. Global Crude Unfractionated Heparin (UFH) Sales Market Share by Application in 2020 Figure 26. Global Crude Unfractionated Heparin (UFH) Revenue Market Share by Application (2016-2021) Figure 27. Global Crude Unfractionated Heparin (UFH) Revenue Market Share by Application in 2020 Figure 28. Japan Crude Unfractionated Heparin (UFH) Sales Growth Rate 2016-2027 (Kiloton) Figure 29. Japan Crude Unfractionated Heparin (UFH) Revenue Growth Rate 2016-2027 (US$ Million) Figure 30. Japan Crude Unfractionated Heparin (UFH) Market Share in Global Market 2016-2027 Figure 31. Japan 5 and 10 Largest Crude Unfractionated Heparin (UFH) Players Market Share by Revenue in Crude Unfractionated Heparin (UFH) in 2020 Figure 32. Japan Crude Unfractionated Heparin (UFH) Revenue Share by Type (2016-2021) Figure 33. Japan Crude Unfractionated Heparin (UFH) Revenue Growth Rate by Type in 2016 & 2020 Figure 34. Japan Crude Unfractionated Heparin (UFH) Revenue Share by Application (2016-2021) Figure 35. Japan Crude Unfractionated Heparin (UFH) Revenue Growth Rate by Application in 2016 & 2020 Figure 36. North America Crude Unfractionated Heparin (UFH) Sales Growth Rate 2016-2021 (Kiloton) Figure 37. North America Crude Unfractionated Heparin (UFH) Revenue Growth Rate 2016-2021 (US$ Million) Figure 38. North America Crude Unfractionated Heparin (UFH) Sales Market Share by Country in 2020 Figure 39. North America Crude Unfractionated Heparin (UFH) Revenue Market Share by Country in 2020 Figure 40. United States Crude Unfractionated Heparin (UFH) Sales Growth Rate (2016-2021) (Kiloton) Figure 41. United States Crude Unfractionated Heparin (UFH) Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Canada Crude Unfractionated Heparin (UFH) Sales Growth Rate (2016-2021) (Kiloton) Figure 43. Canada Crude Unfractionated Heparin (UFH) Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Europe Crude Unfractionated Heparin (UFH) Sales Growth Rate 2016-2021 (Kiloton) Figure 45. Europe Crude Unfractionated Heparin (UFH) Revenue Growth Rate 2016-2021 (US$ Million) Figure 46. Europe Crude Unfractionated Heparin (UFH) Sales Market Share by Country in 2020 Figure 47. Europe Crude Unfractionated Heparin (UFH) Revenue Market Share by Country in 2020 Figure 48. Germany Crude Unfractionated Heparin (UFH) Sales Growth Rate (2016-2021) (Kiloton) Figure 49. Germany Crude Unfractionated Heparin (UFH) Revenue Growth Rate (2016-2021) (US$ Million) Figure 50. France Crude Unfractionated Heparin (UFH) Sales Growth Rate (2016-2021) (Kiloton) Figure 51. France Crude Unfractionated Heparin (UFH) Revenue Growth Rate (2016-2021) (US$ Million) Figure 52. U.K. Crude Unfractionated Heparin (UFH) Sales Growth Rate (2016-2021) (Kiloton) Figure 53. U.K. Crude Unfractionated Heparin (UFH) Revenue Growth Rate (2016-2021) (US$ Million) Figure 54. Italy Crude Unfractionated Heparin (UFH) Sales Growth Rate (2016-2021) (Kiloton) Figure 55. Italy Crude Unfractionated Heparin (UFH) Revenue Growth Rate (2016-2021) (US$ Million) Figure 56. Russia Crude Unfractionated Heparin (UFH) Sales Growth Rate (2016-2021) (Kiloton) Figure 57. Russia Crude Unfractionated Heparin (UFH) Revenue Growth Rate (2016-2021) (US$ Million) Figure 58. Asia Pacific Crude Unfractionated Heparin (UFH) Sales Growth Rate 2016-2021 (Kiloton) Figure 59. Asia Pacific Crude Unfractionated Heparin (UFH) Revenue Growth Rate 2016-2021 (US$ Million) Figure 60. Asia Pacific Crude Unfractionated Heparin (UFH) Sales Market Share by Region in 2020 Figure 61. Asia Pacific Crude Unfractionated Heparin (UFH) Revenue Market Share by Region in 2020 Figure 62. China Crude Unfractionated Heparin (UFH) Sales Growth Rate (2016-2021) (Kiloton) Figure 63. China Crude Unfractionated Heparin (UFH) Revenue Growth Rate (2016-2021) (US$ Million) Figure 64. Japan Crude Unfractionated Heparin (UFH) Sales Growth Rate (2016-2021) (Kiloton) Figure 65. Japan Crude Unfractionated Heparin (UFH) Revenue Growth Rate (2016-2021) (US$ Million) Figure 66. South Korea Crude Unfractionated Heparin (UFH) Sales Growth Rate (2016-2021) (Kiloton) Figure 67. South Korea Crude Unfractionated Heparin (UFH) Revenue Growth Rate (2016-2021) (US$ Million) Figure 68. India Crude Unfractionated Heparin (UFH) Sales Growth Rate (2016-2021) (Kiloton) Figure 69. India Crude Unfractionated Heparin (UFH) Revenue Growth Rate (2016-2021) (US$ Million) Figure 70. Australia Crude Unfractionated Heparin (UFH) Sales Growth Rate (2016-2021) (Kiloton) Figure 71. Australia Crude Unfractionated Heparin (UFH) Revenue Growth Rate (2016-2021) (US$ Million) Figure 72. China Taiwan Crude Unfractionated Heparin (UFH) Sales Growth Rate (2016-2021) (Kiloton) Figure 73. China Taiwan Crude Unfractionated Heparin (UFH) Revenue Growth Rate (2016-2021) (US$ Million) Figure 74. Indonesia Crude Unfractionated Heparin (UFH) Sales Growth Rate (2016-2021) (Kiloton) Figure 75. Indonesia Crude Unfractionated Heparin (UFH) Revenue Growth Rate (2016-2021) (US$ Million) Figure 76. Thailand Crude Unfractionated Heparin (UFH) Sales Growth Rate (2016-2021) (Kiloton) Figure 77. Thailand Crude Unfractionated Heparin (UFH) Revenue Growth Rate (2016-2021) (US$ Million) Figure 78. Malaysia Crude Unfractionated Heparin (UFH) Sales Growth Rate (2016-2021) (Kiloton) Figure 79. Malaysia Crude Unfractionated Heparin (UFH) Revenue Growth Rate (2016-2021) (US$ Million) Figure 80. Latin America Crude Unfractionated Heparin (UFH) Sales Growth Rate 2016-2021 (Kiloton) Figure 81. Latin America Crude Unfractionated Heparin (UFH) Revenue Growth Rate 2016-2021 (US$ Million) Figure 82. Latin America Crude Unfractionated Heparin (UFH) Sales Market Share by Country in 2020 Figure 83. Latin America Crude Unfractionated Heparin (UFH) Revenue Market Share by Country in 2020 Figure 84. Mexico Crude Unfractionated Heparin (UFH) Sales Growth Rate (2016-2021) (Kiloton) Figure 85. Mexico Crude Unfractionated Heparin (UFH) Revenue Growth Rate (2016-2021) (US$ Million) Figure 86. Brazil Crude Unfractionated Heparin (UFH) Sales Growth Rate (2016-2021) (Kiloton) Figure 87. Brazil Crude Unfractionated Heparin (UFH) Revenue Growth Rate (2016-2021) (US$ Million) Figure 88. Argentina Crude Unfractionated Heparin (UFH) Sales Growth Rate (2016-2021) (Kiloton) Figure 89. Argentina Crude Unfractionated Heparin (UFH) Revenue Growth Rate (2016-2021) (US$ Million) Figure 90. Middle East and Africa Crude Unfractionated Heparin (UFH) Sales Growth Rate 2016-2021 (Kiloton) Figure 91. Middle East and Africa Crude Unfractionated Heparin (UFH) Revenue Growth Rate 2016-2021 (US$ Million) Figure 92. Middle East and Africa Crude Unfractionated Heparin (UFH) Sales Market Share by Country in 2020 Figure 93. Middle East and Africa Crude Unfractionated Heparin (UFH) Revenue Market Share by Country in 2020 Figure 94. Turkey Crude Unfractionated Heparin (UFH) Sales Growth Rate (2016-2021) (Kiloton) Figure 95. Turkey Crude Unfractionated Heparin (UFH) Revenue Growth Rate (2016-2021) (US$ Million) Figure 96. Saudi Arabia Crude Unfractionated Heparin (UFH) Sales Growth Rate (2016-2021) (Kiloton) Figure 97. Saudi Arabia Crude Unfractionated Heparin (UFH) Revenue Growth Rate (2016-2021) (US$ Million) Figure 98. UAE Crude Unfractionated Heparin (UFH) Sales Growth Rate (2016-2021) (Kiloton) Figure 99. UAE Crude Unfractionated Heparin (UFH) Revenue Growth Rate (2016-2021) (US$ Million) Figure 100. Crude Unfractionated Heparin (UFH) Value Chain Figure 101. Channels of Distribution Figure 102. Distributors Profiles Figure 103. Bottom-up and Top-down Approaches for This Report Figure 104. Data Triangulation Figure 105. Key Executives Interviewed

Bioiberica Shenzhen Hepalink Sanofi Nanjing King-friend Fengrun Biological Technology Aspen Oss Hebei Changshan Biochemical Changzhou Qianhong Hepac (Darling Ingredients) Huaian MDC Pharmaceutical Yantai Dongcheng Biochemicals